Application

18514478 · OXOINDOLINE COMPOUND FOR THE TREATMENT OF INFLAMMATORY DISEASES OR CANCER

Filed 2023-11-20 · Granted The official file ↗ · Art unit 1629 · Examiner Heather Raquel Dahlin Typical · CPC C07D 401/04 · Hoffmann-La Roche Inc. · GENENTECH, INC.

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

27.6 mo

to disposition 33.4 mo

Statutes raised

101 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.